UK Data Centre Gas Plans Raise Climate Concerns Amid Grid Bottlenecks Newsroom Tech Sector Faces Consolidation Wave as Venture Funding Tightens GIBO GIBO Climbs 268 Resistance at 141 in Focus 20260515 Jim Cramer Highlights TJXs Resilience A Superb Fit for Todays Retail Landscape Spotify Shares Surge 13 on AI Partnership with UMG and Upbeat Guidance at Investor Day BofA Analyst Raises Philip Morris International Price Target Signaling Confidence in SmokeFree Strategy Wall Street Complacency Raises Concerns About Potential Market Correction Sebi Proposes Intraday Option Strike Additions to Manage Market Volatility Markets Increase Probability of Fed Rate Hike After Hot Inflation Data Veralto Corporation Stock Outlook Wall Street Sentiment Remains Divided STIM Q1 2026 Earnings EPS Beats Estimates as Cost Control Shines Revenue Unreported VTEX Q1 2026 Earnings EPS Miss Sends Shares Lower Amid Revenue Uncertainty XPO Q1 2026 Earnings EPS Surges 14 Above Estimates Stock Eases PENN Q1 2026 Earnings EPS Misses Estimates as Stock Surges 119 OZKAP Q1 2026 Earnings Marginal EPS Miss Amid Stable Performance SPRY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment HCA Healthcare Edges Higher on Steady Hospital Demand and Sector Resilience HCA ZoomInfo GTM Slides 3 Key Support Levels Under Scrutiny Donegal Group DGICA Declines 16 as Stock Tests Key Support Levels Codere Online Shares Edge Lower Testing Key Support at 885 Golar LNG GLNG Slips 23 as Traders Eye Support at 4859 After Resistance Test Windex Understanding Product Limitations and Consumer Guidance for SC Johnsons Leading Glass Cleaner NXPI Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Avalon Holdings AWX Edges Higher as Stock Tests Key Resistance Zone OpenAI Moves Closer to Public Listing Amid IPO Filing Reports Melar MACI Flat at 1085 Consolidation Continues 20260520 Elastic NV ESTC Q1 2026 Results Top Views on Strong Revenue Wall Street Slides as Bond Yields Rise on Renewed Inflation Anxiety Calumet CLMT Q1 2026 Results Fall Short EPS 364 Revenue NA PTC Therapeutics PTCT Q1 2026 Beat Revenue NA EPS Exceeds by Significant FiEE FIEE Steady at 631 Awaiting Next Catalyst 20260520